Suchergebnisse - "Srinivas, Nithya"

PubPharm (2)

1

A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic Malignancies

enthalten in: Clinical lymphoma, myeloma & leukemia | 2022

von Zeidan, A. | Cook, R. | Bordoni, R. | +7

2

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

enthalten in: Blood advances | 2020

von Schroeder, M. | Khoury, H. | Jagasia, M. | +14

1
[1]